Drug Discovery World
MARCH 7, 2023
She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials. Prior to Twist Bioscience, she worked at Agilent Technologies and at the University of Houston developing DNA and RNA parallel synthesis processes on solid support.
Drug Discovery World
JANUARY 17, 2024
More specifically, liquid biopsies are used as stratification tools to identify patients most likely to benefit from a targeted treatment, 8 and as an early efficacy-response biomarker for treatment response evaluation in clinical development. 21 In a recent publication, Silvestri et al., 22 Ring et al.,
Drug Discovery World
OCTOBER 6, 2022
Before drugs make it to market they have to pass through a gauntlet of stages involved in clinical trials. As such, patient selection for clinical trials has become an increasingly critical consideration for drug trial success. About the author . Jarret Glasscock is a geneticist and computational biologist.
Expert insights. Personalized for you.
246 
Let's personalize your content